Mayur Ian Somaiya

Mayur Ian Somaiya

50 jaar
Finance
Health Technology
Consumer Services

Profiel

Mayur Ian Somaiya is currently the Chief Financial Officer at NewAmsterdam Pharma Co. NV since 2023.
He previously held managing director and senior research analyst positions at Piper Sandler & Co. (Broker) from 2010 to 2013, managing director positions at Thomas Weisel Partners LLC from 2003 to 2009, managing director and senior analyst positions at Nomura Securities International, Inc. from 2013 to 2016, managing director and analyst positions at BMO Capital Markets Corp.
(Broker) from 2016 to 2018, and was the Chief Financial Officer at TCR2 Therapeutics, Inc. from 2018 to 2021.
He also worked as an analyst at Prudential Securities from 1997 to 1999 and as a senior analyst at Morgan Stanley & Co. LLC from 2000 to 2002.
Additionally, he worked as a consultant at Carson Group, Inc. (New York) in 1996.
Mr. Somaiya received his undergraduate degree from New York University in 1995.

Actieve functies van Mayur Ian Somaiya

Eerdere bekende functies van Mayur Ian Somaiya

BedrijvenFunctieEinde
TCR2 THERAPEUTICS INC. Director of Finance/CFO 10-12-2021
Analyst-Equity 01-04-2018
Analyst-Equity 01-01-2016
Analyst-Equity 31-10-2013
Analyst-Equity 15-10-2009
Ervaring van Mayur Ian Somaiya in detail bekijken

Opleiding van Mayur Ian Somaiya

New York University Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mayur Ian Somaiya in detail bekijken

Connecties

100 +

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

Bedrijven in privébezit8
Prudential Securities

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mayur Ian Somaiya